MLM
BLCM

Mount Lucas Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Mount Lucas Management’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-350
Closed -$43K – 163
2017
Q1 		$43K Buy
350
+150
+75% +$19.6K 0.01% 136
2016
Q4 		$27K Buy
+200
New +$35.5K 0.01% 141

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Mount Lucas Management's BLCM Position: Q2 2017 in Review

Mount Lucas Management sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q2 2017, closing a stake of 350 shares — an estimated $43K sold.

Mount Lucas Management first reported a position in BLCM in Q4 2016 and held it in 2 quarters. The position peaked at $43K in Q1 2017. 84 funds tracked by Wall St. Rank hold BLCM as of Q2 2017.

  • Mount Lucas Management reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
  • Mount Lucas Management sold 350 Bellicum Pharmaceuticals, Inc. shares in Q2 2017, an estimated $43K.
  • Mount Lucas Management first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2016 and held it in 2 quarters.
  • Mount Lucas Management's Bellicum Pharmaceuticals, Inc. position peaked at $43K in Q1 2017.
  • 84 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2017.

Based on Mount Lucas Management's 13F filing for Q2 2017, filed 14 Aug 2017.